Medicare AdvantageCoverageMedium impact
MA06.024i, Noninvasive Techniques for the Evaluation and Monitoring of Individuals with Chronic Liver Disease
Independence Blue Cross·Gastroenterology, Internal Medicine, Family Medicine·Medical Policy
Effective date
Jan 22, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA06.024i covering noninvasive techniques for chronic liver disease evaluation and monitoring has been reissued effective January 22, 2025. This policy update may affect coverage criteria or billing requirements for liver disease diagnostic procedures.
Action Required
By January 22, 2025: Billing team should review the full policy MA06.024i at the provided URL to understand any changes to coverage criteria for noninvasive liver disease evaluation techniques. Update billing protocols and prior authorization requirements as specified in the complete policy text for Medicare Advantage patients with chronic liver disease.